Figure 2.
Figure 2. Induction of OFA-iLRP-specific CTLs by using autologous DCs transfected with OFA-iLRP RNA. DCs from 2 healthy HLA-A2+ individuals were transfected with OFA-iLRP RNA and used to stimulate CTL responses. Cytotoxic reactivity was determined in a 4-hour 51Chromium release assay against HLA-A2+/OFA-iLRP+ hematologic tumor cell lines (A), HLA-A2-/OFA-iLRP+ targets (B), OFA-iLRP-transfected DCs (C), HLA-A2+ CD34+ PBPCs, (D) bone marrow cells from healthy individuals, and (E) HLA-A2+ EBV-transformed lymphoblasts transfected with OFA-iLRP RNA. One of 2 experiments is shown.

Induction of OFA-iLRP-specific CTLs by using autologous DCs transfected with OFA-iLRP RNA. DCs from 2 healthy HLA-A2+ individuals were transfected with OFA-iLRP RNA and used to stimulate CTL responses. Cytotoxic reactivity was determined in a 4-hour 51Chromium release assay against HLA-A2+/OFA-iLRP+ hematologic tumor cell lines (A), HLA-A2-/OFA-iLRP+ targets (B), OFA-iLRP-transfected DCs (C), HLA-A2+ CD34+ PBPCs, (D) bone marrow cells from healthy individuals, and (E) HLA-A2+ EBV-transformed lymphoblasts transfected with OFA-iLRP RNA. One of 2 experiments is shown.

Close Modal

or Create an Account

Close Modal
Close Modal